Genflow Biosciences

“SIRT6 gene therapy aimed at aging, listed in London.”

Genflow (LON:GENF) is developing SIRT6-centric gene therapies for aging and related disease. A public microcap on a map full of privates.

A listed vehicle for a hallmarks bet.

Pre-seed & seed. Filed from the Top Tier Impact landscape.

SIRT6, on the board.

Also in this file